Novel Drug, First Tx for Rare Uveal Melanoma

A novel drug, the first in its class, is also the first treatment approved for use in uveal melanoma, a rare cancer of the eye, after it was shown to improve overall survival.
FDA Approvals

source https://www.medscape.com/viewarticle/967360?src=rss